Skip to main
RSLS
RSLS logo

ReShape Lifesciences (RSLS) Earnings Dates & Reports

ReShape Lifesciences (RSLS) Most Recent Earnings

Report Date
Period EndingQ1 2024
Est. EPS-$232
Actual EPS-$130.50
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ReShape Lifesciences (RSLS) Earnings per Share (EPS) History

Signup for full access
Browse free

ReShape Lifesciences (RSLS) Latest Earnings

The value each RSLS share was expected to gain vs. the value each share gained.

ReShape Lifesciences (RSLS) reported its most recent earnings on for Q1 2024, posting earnings per share (EPS) of -$130.50. This exceeded analysts' expectations of -$232 by 43.75%, marking a Beat.

For comparison, ReShape Lifesciences reported EPS of -$2,262 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

ReShape Lifesciences (RSLS) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025
-$2.25
DeckReportListen
Q1 2025
$18.98
DeckReportListen
Q4 2024
-$47.25
DeckReportListen
Q3 2024
-$77.75
DeckReportListen
Q2 2024
-$87.00
DeckReportListen
View all

ReShape Lifesciences (RSLS) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the ReShape Lifesciences’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

ReShape Lifesciences (RSLS) Earnings FAQs

ReShape Lifesciences (RSLS) last reported earnings on May 15, 2024 for Q1 2024, posting an EPS of -$130.50, which Beat the estimate of -$232 by 43.75%.

For Q1 2024, ReShape Lifesciences (RSLS) reported an EPS of -$130.50, exceeding analysts' estimate of -$232 by 43.75%.

For Q1 2024, ReShape Lifesciences (RSLS) Beat expectations with an actual EPS of -$130.50 vs. an estimated EPS of -$232.

Following the last earnings report on May 15, 2024, ReShape Lifesciences (RSLS)'s stock price moved — from — to —.

The next ReShape Lifesciences (RSLS) earnings call is scheduled for Aug. 14, 2025, where executives will discuss financial results and outlook.

ReShape Lifesciences (RSLS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.